Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism
- 11 August 1999
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1451 (1), 122-131
- https://doi.org/10.1016/s0167-4889(99)00080-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Thiazolidinediones in the Treatment of Insulin Resistance and Type II DiabetesDiabetes, 1996
- Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patientsDiabetologia, 1996
- Thiazolidinediones and Fatty Acids Convert Myogenic Cells into Adipose-like CellsPublished by Elsevier BV ,1995
- Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and
C57BL KsJ-db db Metabolism, 1995 - Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus.Proceedings of the National Academy of Sciences, 1994
- Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitusDiabetes/Metabolism Research and Reviews, 1993
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- In vitro studies on the action of CS-045, a new antidiabetic agentMetabolism, 1990
- Hormonal Regulation of Phosphoenolpyruvate Carboxykinase Gene ExpressionPublished by Springer Science and Business Media LLC ,1985
- Abnormalities in hepatic enzyme activities during development of diabetes in db miceDiabetologia, 1970